NCT00917462 Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE2
NCT00911560 Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00911118 Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer Status COMPLETED Phase PHASE1
NCT00903591 Study of Radiation Exposure and Bilateral Breast Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00902343 Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection Status COMPLETED Phase PHASE3
NCT00901238 Intra-arterial Chemotherapy(Chemosurgery) for Retinoblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00897702 Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer Status COMPLETED Phase N/A
NCT00893945 Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors Status COMPLETED Phase PHASE1
NCT00887809 Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Status COMPLETED Phase PHASE2
NCT00887458 A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy Status COMPLETED Phase PHASE2
NCT00885534 Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00883792 The Northern-European Initiative on Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00877110 Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma Status COMPLETED Phase PHASE1
NCT00870233 Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life Status COMPLETED Phase N/A
NCT00870129 Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors Status RECRUITING Phase NA
NCT00858663 Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00853697 Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00847015 Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2